Medical device company Dynatronics Corporation (NASDAQ:DYNT) disclosed on Tuesday its net income of USD14,000 for Q2 fiscal 2018 ended 31 December 2017.
This is compared with a net loss of USD95,000 for the quarter ended 31 December 2016.
Net sales of USD18.1m were recorded for the Q2 fiscal 2018 ended 31 December 2017, up 107.5% over net sales of USD8.7m in the same period of the prior year.
Gross profit of USD5.8m was announced for the Q2 fiscal 2018 ended 31 December 2017, a rise of 87.7% versus USD3.1m the same prior year quarter.
The company added that the rise in net sales, gross profit and net income were attributable to its acquisitions of Hausmann and Bird & Cronin in the past year.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva